These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 7872320

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC, Hung SC, Tarng DC.
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [Abstract] [Full Text] [Related]

  • 8. The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients.
    Fishbane S, Lynn RI.
    Clin Nephrol; 1995 Oct; 44(4):238-40. PubMed ID: 8575123
    [Abstract] [Full Text] [Related]

  • 9. Intravenous iron dextran and erythropoietin use in pediatric hemodialysis patients.
    Greenbaum LA, Pan CG, Caley C, Nelson T, Sheth KJ.
    Pediatr Nephrol; 2000 Sep; 14(10-11):908-11. PubMed ID: 10975297
    [Abstract] [Full Text] [Related]

  • 10. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia.
    Tarng DC, Wei YH, Huang TP, Kuo BI, Yang WC.
    Kidney Int; 1999 Jun; 55(6):2477-86. PubMed ID: 10354297
    [Abstract] [Full Text] [Related]

  • 11. Assessment of iron status by erythrocyte ferritin in uremic patients with or without recombinant human erythropoietin therapy.
    Caravaca F, Vagace JM, Aparicio A, Groiss J, Pizarro JL, Alonso N, Garcia MC, Arrobas M, Cubero J, Esparrago J.
    Am J Kidney Dis; 1992 Sep; 20(3):249-54. PubMed ID: 1519605
    [Abstract] [Full Text] [Related]

  • 12. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.
    Fishbane S, Frei GL, Maesaka J.
    Am J Kidney Dis; 1995 Jul; 26(1):41-6. PubMed ID: 7611266
    [Abstract] [Full Text] [Related]

  • 13. Sensitivity and specificity of transferrin saturation and serum ferritin as markers of iron status after intravenous iron dextran in hemodialysis patients.
    Low CL, Bailie GR, Eisele G.
    Ren Fail; 1997 Nov; 19(6):781-8. PubMed ID: 9415935
    [Abstract] [Full Text] [Related]

  • 14. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK, Morgenstern T.
    Dtsch Med Wochenschr; 2004 Sep 03; 129(36):1849-53. PubMed ID: 15368155
    [Abstract] [Full Text] [Related]

  • 15. The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data.
    Pollak VE, Lorch JA, Shukla R, Satwah S.
    BMC Nephrol; 2009 Feb 26; 10():6. PubMed ID: 19245700
    [Abstract] [Full Text] [Related]

  • 16. Effect of an intravenous iron dextran regimen on iron stores, hemoglobin, and erythropoietin requirements in hemodialysis patients.
    Park L, Uhthoff T, Tierney M, Nadler S.
    Am J Kidney Dis; 1998 May 26; 31(5):835-40. PubMed ID: 9590194
    [Abstract] [Full Text] [Related]

  • 17. An evaluation of the effectiveness of oral iron therapy in hemodialysis patients receiving recombinant human erythropoietin.
    Markowitz GS, Kahn GA, Feingold RE, Coco M, Lynn RI.
    Clin Nephrol; 1997 Jul 26; 48(1):34-40. PubMed ID: 9247776
    [Abstract] [Full Text] [Related]

  • 18. A study of parenteral iron regimens in hemodialysis patients.
    Besarab A, Kaiser JW, Frinak S.
    Am J Kidney Dis; 1999 Jul 26; 34(1):21-8. PubMed ID: 10401011
    [Abstract] [Full Text] [Related]

  • 19. Mathematical approach for estimating iron needs in hemodialysis patients on erythropoietin therapy.
    Tarng DC, Huang TP, Chen TW.
    Am J Nephrol; 1997 Jul 26; 17(2):158-64. PubMed ID: 9096447
    [Abstract] [Full Text] [Related]

  • 20. National perspective on iron therapy as a clinical performance measure for maintenance hemodialysis patients.
    Owen WF, Szczech L, Johnson C, Frankenfield D.
    Am J Kidney Dis; 1999 Oct 26; 34(4 Suppl 2):S5-S11. PubMed ID: 10516369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.